Read the passage very carefully and answer the questions.
Good med Abroad Is Good Med fir Home
The directorate general of foreign Trade (DGFT) has made it mandatory for all cough syrup exporters to have their products tested and certified for quality at specified government elaborates before shipping out export orders. This is welcome. It will begin the reputation damage over alleged indian cough syrup-related deaths in some countries last year. safeguarding quality cannot be limited to some products or to exports.
Ensuring Quality is the central Drugs Standard control organization's (CDSCO) Responsibility, not DGFT's setting norms for exports is like applying a band-aid to a wound that requires stiches. CDSCO needs an overhaul. In the current fragmented system. Quality and standardization are causalities. A modern ,Independent, statutory regulatory system that has the capacity to provide oversight complex pharmaceutical industry while protecting public health and patient right s required. CDSCO is the non-statutory regulator under the health ministry It has no jurisdiction over state Drug Regulatory Authorities (SDRA's) that are part of state health departments. Each regulators body acts independent of the other. this must change. the regulatory approach, too, needs to change shifting from an overwhelming focus on manufacturing to public health requires putting a doctor in change, and shifting the regulators with multidisciplinary teams.
India is the third-largest pharma manufacturing meeting 20% of global generic demand. The $41 billion industry is estimated to grow further -$50-65 billion by 2025, and $120-130 billion by 20230. Ensuring all indian pharma products meets Quality standards will help both at home and abroad, while growing India's pharma footprint